Holen Sie sich die Stockscreener-App
10.52
7.35%
0.72
Schlusskurs vom Vortag:
$9.80
Offen:
$10.14
24-Stunden-Volumen:
1.36M
Relative Volume:
1.57
Marktkapitalisierung:
$915.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-106.81M
KGV:
-3.1766
EPS:
-3.3117
Netto-Cashflow:
$-8.40M
1W Leistung:
+10.62%
1M Leistung:
-3.04%
6M Leistung:
+13.00%
1J Leistung:
-26.02%
1-Tages-Spanne:
$10.06
$10.65
1-Wochen-Bereich:
$9.13
$10.65
52-Wochen-Spanne:
$5.1501
$16.73
Immunome Inc Stock (IMNM) Company Profile
Firmenname
Immunome Inc
Sektor
Branche
Telefon
610-321-3700
Adresse
18702 N. CREEK PARKWAY, BOTHELL
Vergleichen Sie IMNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
10.52 | 853.04M | 0 | -106.81M | -8.40M | -3.3117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2025-04-02 | Eingeleitet | Lake Street | Buy |
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-30 | Eingeleitet | JP Morgan | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-01-29 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-19 | Eingeleitet | Wedbush | Outperform |
| 2021-10-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Immunome Inc Aktie (IMNM) Neueste Nachrichten
IMNM.O Surges 7.35% with No Fundamental Catalyst — What's Behind the Move? - AInvest
What Caused Immunome’s Sharp Intraday Surge? - AInvest
IMNM.O (Immunome) Surges 7.35%: A Deep Dive Into the Unusual Intraday Move - AInvest
How sensitive is Immunome Inc. to inflationInsider Selling & High Yield Equity Trading Tips - classian.co.kr
Will earnings trigger a reversal in Immunome Inc.2025 Top Decliners & Technical Entry and Exit Alerts - Newser
Analyzing net buyer seller activity in Immunome Inc.Weekly Profit Report & Expert Curated Trade Setup Alerts - Newser
What Spooked Immunome’s 7.35% Intraday Move? A Technical Deep Dive - AInvest
IMNM.O Surges 7.35% Intraday: Unpacking the Sudden Move - AInvest
Is Immunome Inc. benefiting from innovation trendsEarnings Overview Summary & Expert Verified Movement Alerts - خودرو بانک
Visual trend scoring systems applied to Immunome Inc.Market Activity Report & Technical Pattern Based Signals - Newser
Will Immunome Inc. price bounce be sustainableEntry Point & Expert Curated Trade Setup Alerts - Newser
Immunome (IMNM.O) Surges 5.66% — What’s Behind the Unusual Move? - AInvest
Best data tools to analyze Immunome Inc. stockMarket Volume Summary & Stock Portfolio Risk Management - Newser
Craig-Hallum Initiates Coverage on Immunome (IMNM) with 'Buy' Ra - GuruFocus
Using data models to predict Immunome Inc. stock movementJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser
Immunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’ - Asianet Newsable
When is the best time to exit Immunome Inc.Earnings Recap Summary & Growth Focused Stock Pick Reports - Newser
Using Bollinger Bands to evaluate Immunome Inc.July 2025 Pullbacks & Weekly High Return Opportunities - Newser
Is Immunome Inc. part of any ETF2025 Winners & Losers & Community Verified Swing Trade Signals - خودرو بانک
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 563 - GuruFocus
Using data filters to optimize entry into Immunome Inc.July 2025 Market Mood & AI Powered Market Entry Strategies - Newser
Is a relief rally coming for Immunome Inc. holdersJuly 2025 PostEarnings & Weekly High Return Opportunities - Newser
Can Immunome Inc. maintain its current growth rateWeekly Stock Analysis & Verified Swing Trading Watchlist - خودرو بانک
Risk vs reward if holding onto Immunome Inc.Trend Reversal & Expert Approved Momentum Ideas - Newser
Regression analysis insights on Immunome Inc. performanceJuly 2025 Outlook & Daily Chart Pattern Signals - Newser
Is Immunome Inc. trending in predictive chart modelsJuly 2025 Snapshot & Fast Moving Market Watchlists - Newser
Is Immunome Inc. a candidate for recovery playJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - Newser
Using Ichimoku Cloud for Immunome Inc. technicalsWeekly Trend Recap & Step-by-Step Swing Trade Plans - Newser
How does Immunome Inc. perform in inflationary periodsJuly 2025 Patterns & Fast Exit and Entry Trade Guides - khodrobank.com
Published on: 2025-09-03 09:01:24 - Newser
Iovance Biotherapeutics shares rise 1.32% premarket after Immunome's presentation at H.C. Wainwright conference. - AInvest
Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
Will Immunome Inc. continue its uptrendMarket Risk Report & AI Enhanced Execution Alerts - Newser
Why Immunome Inc. stock attracts strong analyst attention2025 Performance Recap & Step-by-Step Swing Trade Plans - Newser
Price momentum metrics for Immunome Inc. explainedMarket Risk Summary & Safe Swing Trade Setup Alerts - Newser
What is the long term forecast for Immunome Inc. stockMarket Performance Recap & High Conviction Trade Alerts - خودرو بانک
Immunome, Inc. (NASDAQ:IMNM) Given Average Recommendation of “Buy” by Analysts - Defense World
Can Traders Expect Breakout From Immunome Inc. This Week2025 Geopolitical Influence & AI Enhanced Market Trend Forecasts - beatles.ru
Will Immunome Inc. bounce back from current supportTrade Volume Report & Real-Time Volume Surge Alerts - Newser
Is Immunome Inc. building a consolidation baseInsider Buying & Daily Entry Point Trade Alerts - Newser
Analyzing recovery setups for Immunome Inc. investorsJobs Report & Daily Momentum Trading Reports - Newser
Nuveen LLC Takes Position in Immunome, Inc. $IMNM - Defense World
Trend Dashboard Flags Immunome Inc. As Potential Swing Trade getLinesFromResByArray error: size == 0 - sisaissue.com
Finanzdaten der Immunome Inc-Aktie (IMNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):